Skip to main content
. 2024 Jan 13;12(1):175. doi: 10.3390/biomedicines12010175
SPMs specialized pro-resolving mediators
MDSCs myeloid-derived suppressor cells
CRS cytokine release syndrome
ILCs innate lymphoid cells
PAMPs pathogen-associated molecular patterns
PRRs pattern recognition receptors
iPRRs inhibitory pattern recognition receptors
LPS lipopolysaccharide
NF-κB nuclear factor kappa light chain enhancer of activated B cells
APC antigen-presenting cell
TCR T-cell receptor
IFN-γ interferon gamma
TNF-α tumor necrosis factor alpha
TLR2 Toll-like receptor 2
IL-4 interleukin 4
IL-6 interleukin 6
IL-7 interleukin 7
IL-8 interleukin 8
IL-10 interleukin 10
IL-13 interleukin 13
GM-CSF granulocyte macrophage colony-stimulating factor
M-CSF macrophage colony-stimulating factor
ICs immune complexes
GCs glucocorticoids
LIF leukemia inhibitory factor
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
PD-1 programmed cell death protein 1
PD-L1 programmed death ligand 1
CLP cecal ligation and puncture
HLA-DR human leukocyte antigen DR isotype
ET endotoxin tolerance
HMGB1 high mobility group box 1
ROS reactive oxygen species
Bcl-2 B cell lymphoma 2
FasL Fas ligand
Bax Bcl-2-associated X protein
Bak Bcl-2 antagonist killer 1
LTx lethal toxin
TUNEL transferase-mediated dUTP nick-end labeling
G-CSF granulocyte colony-stimulating factor
CXCL2 chemokine ligand 2
ICU intensive care unit
M-MDSCs monocytic MDSCs
PMN-MDSCs polymorphic MDSCs
GPR18 G-protein-coupled receptor 18
RvD1 resolvin D1
RvD2 resolvin D2
PTX3 pentraxin 3
HLA human leukocyte antigen
MHC major histocompatibility complex
APC antigen-presenting cell
SOFA sequential organ failure assessment
AA arachidonic acid
EPA eicosapentaenoic acid
DHA docosahexaenoic acid